Guangdong Kanghua Healthcare Group Co., Ltd. (FRA:E9Q)

FRA:E9Q Statistics

Total Valuation

FRA:E9Q has a market cap or net worth of EUR 66.67 million. The enterprise value is 15.67 million.

Market Cap	66.67M
Enterprise Value	15.67M

Important Dates

The last earnings date was Friday, November 28, 2025.

Earnings Date	Nov 28, 2025
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	84.39M
Shares Outstanding	n/a
Shares Change (YoY)	n/a
Shares Change (QoQ)	n/a
Owned by Insiders (%)	77.25%
Owned by Institutions (%)	1.52%
Float	37.41M

Valuation Ratios

The trailing PE ratio is 7.33.

PE Ratio	7.33
Forward PE	n/a
PS Ratio	0.27
PB Ratio	0.38
P/TBV Ratio	0.43
P/FCF Ratio	1.82
P/OCF Ratio	1.48
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 0.63, with an EV/FCF ratio of 0.43.

EV / Earnings	1.72
EV / Sales	0.06
EV / EBITDA	0.63
EV / EBIT	2.19
EV / FCF	0.43

Financial Position

The company has a current ratio of 1.30, with a Debt / Equity ratio of 0.24.

Current Ratio	1.30
Quick Ratio	1.19
Debt / Equity	0.24
Debt / EBITDA	1.61
Debt / FCF	1.16
Interest Coverage	25.76

Financial Efficiency

Return on equity (ROE) is 4.68% and return on invested capital (ROIC) is 2.67%.

Return on Equity (ROE)	4.68%
Return on Assets (ROA)	1.78%
Return on Invested Capital (ROIC)	2.67%
Return on Capital Employed (ROCE)	4.08%
Revenue Per Employee	63,604
Profits Per Employee	2,371
Employee Count	4,320
Asset Turnover	0.75
Inventory Turnover	24.84

Taxes

In the past 12 months, FRA:E9Q has paid 6.11 million in taxes.

Income Tax	6.11M
Effective Tax Rate	43.17%

Stock Price Statistics

The stock price has decreased by -14.22% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-14.22%
50-Day Moving Average	0.19
200-Day Moving Average	0.19
Relative Strength Index (RSI)	43.19
Average Volume (20 Days)	n/a

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, FRA:E9Q had revenue of EUR 243.99 million and earned 9.10 million in profits. Earnings per share was 0.03.

Revenue	243.99M
Gross Profit	39.70M
Operating Income	9.18M
Pretax Income	14.16M
Net Income	9.10M
EBITDA	21.32M
EBIT	9.18M
Earnings Per Share (EPS)	0.03

Balance Sheet

The company has 94.12 million in cash and 42.58 million in debt, giving a net cash position of 51.54 million.

Cash & Cash Equivalents	94.12M
Total Debt	42.58M
Net Cash	51.54M
Net Cash Per Share	n/a
Equity (Book Value)	174.10M
Book Value Per Share	0.52
Working Capital	31.66M

Cash Flow

In the last 12 months, operating cash flow was 44.94 million and capital expenditures -8.38 million, giving a free cash flow of 36.56 million.

Operating Cash Flow	44.94M
Capital Expenditures	-8.38M
Free Cash Flow	36.56M
FCF Per Share	n/a

Margins

Gross margin is 16.27%, with operating and profit margins of 3.76% and 3.73%.

Gross Margin	16.27%
Operating Margin	3.76%
Pretax Margin	5.80%
Profit Margin	3.73%
EBITDA Margin	8.74%
EBIT Margin	3.76%
FCF Margin	14.99%

Dividends & Yields

FRA:E9Q does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	n/a
Shareholder Yield	n/a
Earnings Yield	13.64%
FCF Yield	54.84%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

FRA:E9Q has an Altman Z-Score of 1.52 and a Piotroski F-Score of 6. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	1.52
Piotroski F-Score	6